|
|
|
Volumn , Issue 13, 2007, Pages 1-81
|
|
Toxicology and carcinogenesis study of glycidol (CAS No. 556-52-5) in genetically modified haploinsufficient p16(Ink4a)/p19(Arf) mice (gavage study).
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARCINOGEN;
CDKN2A PROTEIN, MOUSE;
CYCLIN DEPENDENT KINASE INHIBITOR 2A;
EPOXIDE;
GLYCIDOL;
PROPANOL;
UNCLASSIFIED DRUG;
ADENOMA;
ANIMAL;
ARTICLE;
BRAIN;
CARCINOGEN TESTING;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
FEMALE;
GENETICS;
HISTIOCYTIC SARCOMA;
LUNG TUMOR;
MALE;
MOUSE;
NERVE CELL;
PAPILLOMA;
PATHOLOGY;
STOMACH TUMOR;
TRANSGENIC MOUSE;
ADENOMA;
ANIMALS;
BRAIN;
CARCINOGENICITY TESTS;
CARCINOGENS;
CYCLIN-DEPENDENT KINASE INHIBITOR P16;
EPOXY COMPOUNDS;
FEMALE;
HISTIOCYTIC SARCOMA;
LUNG NEOPLASMS;
MALE;
MICE;
MICE, TRANSGENIC;
NEURONS;
PAPILLOMA;
PROPANOLS;
STOMACH NEOPLASMS;
|
|
EID: 58149346089
PISSN: None
EISSN: 15565246
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|